Redirected, genetically-engineered t regulatory cells and their use in suppression of autoimmune and inflammatory disease

a technology of t-regulatory cells and autoimmune diseases, applied in the field of immunology and medicine, can solve the problems of inability to successfully vaccinate tumor patients with a large variety of tumor-associated antigen vaccines, inability inability to effectively vaccinate patients with ibd, etc., to suppress t-regulatory cells, suppress t-regulatory cells, and suppress t-regulatory

a technology of t-regulatory cells and autoimmune diseases, applied in the field of immunology and medicine, can solve the problems of inability to successfully vaccinate tumor patients with a large variety of tumor-associated antigen vaccines, inability inability to effectively vaccinate patients with ibd, etc., to suppress t-regulatory cells, suppress t-regulatory cells, and suppress t-regulatory

US20100135974A1Inactive Publication Date: 2010-06-03YEDA RES & DEV CO LTD

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Redirected, genetically-engineered t regulatory cells and their use in suppression of autoimmune and inflammatory disease
  • Redirected, genetically-engineered t regulatory cells and their use in suppression of autoimmune and inflammatory disease
  • Redirected, genetically-engineered t regulatory cells and their use in suppression of autoimmune and inflammatory disease

Examples

Experimental program
Comparison scheme
Effect test

example i

Phenotypic Characterization of TNP-Specific Tregs

[0280]The inventors have produced transgenic (Tg) mice expressing a TNP-specific tripartite chimeric receptor (TpCR) that serve as a source of redirected Treg cells specific for the trinitrophenyl (TNP) hapten. This hapten has served as a “classical” antigen for years in studying both antibodies and T cell-mediated immunity. A chemically reactive form of this hapten, TNBS, is a contact sensitizing agent that induces and evokes delayed-type hypersensitivity (DTH) responses as well as inducing colitis in animals, as described herein.

[0281]Generation of TNP-specific Tregs was achieved by the creation of Tg mice that express TNP-specific TpCR that comprises an scFv from the TNP-specific mAb Sp6 mAb linked to a truncated CD28 molecule which was inserted between the scFv and the cytoplasmic part of the FcRγ chain (abbreviated as y herein (see FIG. 1). This construct includes the hinge region, transmembrane region, and cytoplasmic region of ...

example ii

Isolation of Trees in which TNP-Specific TpCR are Highly Expressed

[0285]Tregs were isolated using double magnetic bead separation (Miltenyi Biotech) or by fluorescent cell sorting in which fluorescently labeled CD4+CD25+ cells were sorted using the FACSARIA cell sorting system.

[0286]Treg expression of TNP-specific TpCR was assessed by containing cells for Foxp3 (considered the “gold standard” marker of Tregs) and PE-labeled mAb specific for TNP antibody (generated in the inventors' laboratory). Controls included groups stained with the appropriate isotype controls. As is shown in FIG. 2, Tregs from TNP-Tg mice, but not from wild-type mice, expressed high levels of TNP-specific TpCR.

example iii

TNP-Tg Mice Posses Increased Numbers of Foxp3+Tree Population

[0287]Peripheral lymphocytes from the spleen as well as gut-associated lymphocytes from the lamina propria of the colon were stained. As shown in FIG. 3, a CD4+CD25+ cell population (represented as the ratio of CD4+CD25+ cells among CD4+T-cells) was elevated modestly in TNP-Tg mice in comparison to control mice (wildtype, ErbB2-Tg and TNP-CD28 null-Tg mice). In contrast, higher numbers of Foxp3+ cells were observed in TNP-Tg animals compared to the control animals in comparison to all other mouse types (FIG. 4).

[0288]To resolve what may have appeared to be an inconsistency between the highly elevated Foxp3+Treg population in TNP-Tg mice and the modestly elevated CD4+CD25+ Treg population in these mice, effector CD4+CD25− cells were isolated by cell sorting to a level of 99% purity. Isolated cells were stained for Foxp3 (FIG. 5). As expected, no positive Foxp3 staining was noted in T effector cells from wildtype, ErbB2-Tg a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
outer diameteraaaaaaaaaa
Login to View More

Abstract

A redirected Treg cell is endowed with specificity toward a selected target antigen or ligand. The cell contains a chimeric receptor polypeptide that is expressed in a single, continuous chain, with an extracellular recognition region displayed on the surface of the cell, a transmembrane region and an intracellular signaling region. The extracellular recognition region is specific for the selected target antigen or ligand. The intracellular signaling region includes a combination of T-cell signaling polypeptide moieties, which combination, upon binding of the extracellular recognition region to the selected target antigen or ligand, triggers activation of the redirected Treg cells to cause suppression of T-cell mediated immunity. Such redirected Treg cells may be used to suppress undesired activity of T effector cells thereby mediating an immune or inflammatory response. They are particularly useful in treating T effector cell-mediated diseases, such as inflammatory bowel disease, transplant rejection and GVH disease.

Description

BACKGROUND OF THE INVENTION[0001]1. Field of the Invention[0002]The invention in the field of immunology and medicine relates to genetic modification of T regulatory cells with chimeric receptors with antibody-type specificity, and the use of such cells to suppress the action of T effector cells and treat any of a number of diseases and conditions in which such suppression is beneficial, primarily autoimmune and inflammatory diseases such as inflammatory bowel diseases (IBD), organ-specific autoimmune diseases, allograft rejection and Graft-vs. Host disease.[0003]2. Description of the Background Art[0004]Regulatory T-Cells (Tregs)[0005]One line of research that led to discovery of Treg cells was the observation that thymectomy of mice of certain susceptible strains on postnatal day 3 results in a spectrum of organ-specific autoimmune effects, which were preventable by “reconstitution” of these animals early in life with normal adult lymphocytes (Asano M et al., J Exp Med 1996; 184:3...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
03 Jun 2010
Publication
US20100135974A1
IPC
A61K35/12; C12N5/10; C07H21/04; C07K16/00; A61P29/00; A61P37/00; A61K39/00; C12N5/0783
CPC
A61K39/0008; C12N5/0636; A61K39/0011; A61P29/00; A61P37/00; A61K39/464406; A61K39/4621; A61K39/4611
Inventors
ESHHAR, ZELIG; ELINAV, ERAN